"As use of this medication is extended and expanded for weight loss and other health advocacy, there is an opportunity to do much more, including product development, packaging, online and in-store merchandising, education, and promotion." Opportunities include: Merchandise dietary and nutritional support items near the pharmacy in drug and grocery, improving the shopping experience for consumers taking GLP-1s Understand that 91% of Millennials, 90% of Gen Z, and 64% of Gen X on GLP-1 medications are interested in packaged foods that support their weight loss goals, and they want messaging called out on the package Meet consumers where they are with product and health information, amplifying digital commerce programming Advance opportunities on retailer apps and websites to support these shoppers Acosta Group's "GLP-1 & The Weight Loss Revolution Shopper Insights Study" was conducted Feb
It is not for human consumption, therapeutic use, or diagnostic use
Read more here: nature.com/articles/s4143 #Ophthalmology With #GLP-1 receptor agonists like semaglutide rising in use for diabetes & obesity, concerns are surfacing about possible ocular side effectsespecially NAION, a serious optic neuropathy
Twice-daily exenatide should be administered within 60 minutes before morning and evening meals for optimal post-meal glucose control
Only 28% are specifically seeking better blood sugar control or metabolic improvements
Amblee A